CTT PHARMACEUTICAL HOLDINGS, INC.

CIK 1035422 · CEO · last filed 2025-12-17

CTT PHARMACEUTICAL HOLDINGS, INC. is a CEO who has filed 50 SEC Form 4 insider transactions across 0 companies.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

0

Total Filings

50

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
No companies on record.

Recent Filings

50 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-12-17 Buy (P) +8,300 $456
2025-11-24 Buy (P) +200,000 $8.0K
2025-11-21 Buy (P) +62,900 $2.5K
2025-10-31 Buy (P) +7,000 $420
2025-10-07 Buy (P) +6,815 $409
2025-09-23 Mixed +794,085 $32.0K
2025-08-01 Buy (P) +15,800 $553
2025-07-08 Buy (P) +8,000 $240
2025-06-30 Buy (P) +39,600 $990
2025-06-23 Buy (P) +16,100 $402
Showing 110 of 50
Page 1 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.